Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 7 | |
Outperform | 6 | |
Hold | 5 | |
Sell | 0 | |
Strong Sell | 1 |
Share price forecast in USD
The 18 analysts offering 12 month price targets for Blueprint Medicines Corp have a median target of 128.50, with a high estimate of 167.00 and a low estimate of 81.00. The median estimate represents a 27.44% increase from the last price of 100.83.
High | 65.6% | 167.00 |
Med | 27.4% | 128.50 |
Low | -19.7% | 81.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 13, 2025.
Average growth rate | +3.01% |
Average growth rate | +12.78% |
More ▼
Revenue history & estimates in USD
Average growth rate | +24.33% |
Average growth rate | +262.90% |
More ▼